Tag Archives: Patents

Supreme Court to Review Divided Infringement

The U.S. Supreme Court has agreed to review a Federal Circuit decision that could impact the enforcement of patents covering certain technologies relevant to the personalized medicine industry, e.g., patented diagnostic methods and digital health. On January 10, 2014, the Court granted certiorari in Limelight Networks v. Akamai Technologies (12-786), to review the issue of … Continue reading this entry

Personalized Medicine Market Growing Amid Challenges

On the same day that the personalized medicine testing market was reported to have exceeded $28 billion in 2011, the New England Journal of Medicine (NEJM) also reported a perceived stumble to the use of genomic tests that serve personalized medicine.… Continue reading this entry

Winning Strategies for Personalized Medicine

On October 14, 2011 during Foley & Lardner’s life sciences conference “Winning Strategies: How to Create, Grow and Sustain a Successful Life Sciences Company”, I hosted a panel of industry experts speaking to the challenges and opportunities in realizing the promise of personalized medicine. While much progress has been made in removing legal, technical and … Continue reading this entry